Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Richard Bernstein Advisors LLC

Richard Bernstein Advisors LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 22.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,040 shares of the medical equipment provider's stock after selling 2,960 shares during the period. Richard Bernstein Advisors LLC's holdings in Intuitive Surgical were worth $5,240,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the 4th quarter valued at about $28,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $38,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Down 2.9 %

ISRG opened at $573.74 on Wednesday. The firm has a market cap of $204.35 billion, a PE ratio of 89.51, a P/E/G ratio of 5.85 and a beta of 1.39. The business has a fifty day simple moving average of $567.01 and a 200-day simple moving average of $527.27. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the business's stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 188 shares of the firm's stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company's stock, valued at approximately $4,720,023. The trade was a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,240 shares of company stock valued at $3,529,040 over the last three months. Insiders own 0.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ISRG. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays raised their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective for the company. Finally, Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.